Nuclear Medicine & Molecular Imaging Clinical Trials

Study Title Prinicipal Investigator Stanford Study Status
Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Patients With Inoperable, Somatostatin Receptor Positive, Midgut Carcinoid Tumors, Progressive Under Somatostatin Analogue Therapy

Erik Mittra

Recruiting
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy

Sanjiv Sam Gambhir, MD, PhD

Recruiting
18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Sanjiv Sam Gambhir, MD, PhD

Recruiting
Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer

Elizabeth Kidd

Recruiting
Combined 18F NaF/18F FDG PET/MRI for Detection of Skeletal Metastases

Andrei Iagaru

Recruiting
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Sanjiv Sam Gambhir, MD, PhD

Recruiting
68Ga-PSMA PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Andrei Iagaru

Recruiting
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

Andrei Iagaru

Recruiting
Yttrium Y 90 Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

Andrei Iagaru

Recruiting
Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT Recruiting
68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Andrei Iagaru

Recruiting
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Andrei Iagaru

Recruiting